Pathologica · 2000
[Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically].
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pozzi B, Hotz A M, Feltri M, Cornaggia M, Campiotti L, Bonato M, Pinotti G, Capella C
Аннотация
Based on the histological criteria proposed by the REAL and adopted by the WHO Classification, 30 cases of MALT type lymphoma, 18 cases of diffuse large B cell lymphoma (DLCL), and 17 cases of DLCLs, associated with a MALT type, were identified in a series of 65 surgically treated primary gastric lymphomas. The clinical records of the patients were analyzed retrospectively and the resected specimens were immunostained for bcl-2, p53 and Ki-67. Primary gastric DLBCLs, with or without a MALT type component, disclosed a higher stage of local extension, a more frequent nodal involvement and a significantly worse survival than pure MALT types. High p53 expression and high proliferation rate correlated with the presence of a large cell component and appeared useful for its identification in mixed forms. Low bcl-2 expression discriminated DLCL from DLCL/MALT. Tumor size, stage and Mib-1 index revealed a value in predicting prognosis.
Предметные рубрики MeSH
AdultAgedAged, 80 and overAntigens, BacterialAntigens, CDAntigens, NuclearBiomarkers, TumorCombined Modality TherapyFemaleGastritisHelicobacter InfectionsHelicobacter pyloriHumansItalyKeratinsKi-67 AntigenLife TablesLymphoma, B-Cell, Marginal ZoneLymphoma, Large B-Cell, DiffuseMaleMiddle AgedNeoplasm InvasivenessNeoplasm ProteinsNeoplasm StagingNuclear ProteinsPhenotypeProto-Oncogene Proteins c-bcl-2Retrospective StudiesStomach NeoplasmsSurvival AnalysisTumor Suppressor Protein p53